Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/2241
Title: Magnesium sulphate for treatment of eclampsia: the Nigerian experience
Authors: Adewole1, I F
Oladokun, A
Okewole, AI
Omigbodun, AO
Afolabi, A
Ekele, B
Obed, Y
Audu, LR
Keywords: Eclampsia,,,
maternal mortality
magnesium sulphate
anticonvulsants
Issue Date: 2000
Publisher: COLLEGE OF MEDICINE
Citation: Afr J. Med. meci. Sci. (2000) 29. 239 - 241
Abstract: The preliminary result of an ongoing study in 4 major hK°/Pc^IS across NiSeria on the use of magnesium sulphate (MgS04)as an anticonvulsant in the management of eclampsia is presented. All the 21 obstetric patients with eclampsia (recruited so far) were treated with Mg S04 as the only anticonvulsant. All the patients responded well to the treatment regime in terms of control of fit, and remained conscious thereafter. There was no incidence of severe adverse reactions to the drug. The mean number of convulsions in the patients treated was 4. The observed side effects were nausea vomiting and dizziness in 3 patients and there were 3 perinatal deaths. The findings so far on maternal and fetal outcomes support the routine administration of MgS04 as the drug of choice for the control of convulsion in women with eclampsi
Description: Article
URI: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/2241
ISSN: 1116-4077
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Fawole et al Magnesium _2000.pdfArticle8.28 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.